ÇÏÁö ÀÓÇöõÆ® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Zimmer Biomet Holdings, Inc.; Stryker Corporation; DePuy Synthes(a Johnson & Johnson company); Smith & Nephew plc; and Wright Medical Group.ÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ ÇÏÁö ÀÓÇöõÆ® ½ÃÀå ÀλçÀÌÆ®
½ÃÀå ÇöȲ
ÇÏÁö ÀÓÇöõÆ® ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ ¹× ±âȸ
Àúħ½À ¼ö¼ú ¼ö¿ä Áõ°¡
3D ÇÁ¸°ÆÃ ±â¼úÀÇ ÅëÇÕ
¾ïÁ¦¿äÀÎ ¹× °úÁ¦
ÀÓÇöõÆ® ¹× ¼ö¼úÀÇ °í°¡ÀÇ ºñ¿ë
PESTEL ºÐ¼®
ÇÏÁö ÀÓÇöõÆ® ½ÃÀå µ¿Çâ
¹ë·ùüÀÎ ºÐ¼®
COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ ÇÏÁö ÀÓÇöõÆ® ½ÃÀå : À¯Çüº°
ÁÖ¿ä Á¶»ç °á°ú
¼¹®
¹«¸
¾ûµ¢ÀÌ
¹ß°ú ¹ß¸ñ
Á¦6Àå ¼¼°èÀÇ ÇÏÁö ÀÓÇöõÆ® ½ÃÀå : ¹ÙÀÌ¿À Àç·áº°
ÁÖ¿ä Á¶»ç °á°ú
¼¹®
±Ý¼Ó ¹ÙÀÌ¿À Àç·á
¼¼¶ó¹Í ¹ÙÀÌ¿À Àç·á
õ¿¬ ¹ÙÀÌ¿À Àç·á
°íºÐÀÚ ¹ÙÀÌ¿À Àç·á
Á¦7Àå ¼¼°èÀÇ ÇÏÁö ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ ¿ëµµº°
ÁÖ¿ä Á¶»ç °á°ú
¼¹®
º´¿ø
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
Ŭ¸®´Ð
Á¦8Àå ¼¼°èÀÇ ÇÏÁö ÀÓÇöõÆ® ½ÃÀå : Áö¿ªº°
ÁÖ¿ä Á¶»ç °á°ú
¼¹®
ÇÏÁö ÀÓÇöõÆ® ½ÃÀå Æò°¡ : Áö¿ªº°(2020-2034³â)
ºÏ¹Ì
ºÏ¹Ì : À¯Çüº°(2020-2034³â)
ºÏ¹Ì : ¹ÙÀÌ¿À Àç·áº°(2020-2034³â)
ºÏ¹Ì : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
¹Ì±¹
ij³ª´Ù
À¯·´
À¯·´ : À¯Çüº°, 2020-2034
À¯·´ : ¹ÙÀÌ¿À Àç·áº°(2020-2034³â)
À¯·´ : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
¿µ±¹
ÇÁ¶û½º
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
³×´ú¶õµå
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç : À¯Çüº°(2020-2034³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : ¹ÙÀÌ¿À Àç·áº°(2020-2034³â)
¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
Áß±¹
Àεµ
¸»·¹À̽þÆ
ÀϺ»
Àεµ³×½Ã¾Æ
Çѱ¹
È£ÁÖ
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À¯Çüº°(2020-2034³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¹ÙÀÌ¿À Àç·áº°(2020-2034³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
À̽º¶ó¿¤
³²¾ÆÇÁ¸®Ä«
±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : À¯Çüº°(2020-2034³â)
¶óƾ¾Æ¸Þ¸®Ä« : ¹ÙÀÌ¿À Àç·áº°(2020-2034³â)
¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ ¿ëµµº°(2020-2034³â)
¸ß½ÃÄÚ
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
È®´ë ¹× Àμö ºÐ¼®
È®´ë
Àμö
Á¦ÈÞ, Çù¾÷, ÇÕÀÇ ¹× °ø°³
Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
Zimmer Biomet Holdings, Inc.
Stryker Corporation
DePuy Synthes(a Johnson & Johnson company)
Smith & Nephew plc
Wright Medical Group NV
Exactech, Inc.
Medacta International SA
Orthofix Medical Inc.
Conformis, Inc.
Globus Medical, Inc.
NuVasive, Inc.
Arcam AB(a part of GE Additive)
CeramTec GmbH
MicroPort Orthopedics
DJO Global, Inc.
AJY
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
The lower extremity implants market size is expected to reach USD 18.43 billion by 2034, according to a new study by Polaris Market Research. The report "Lower Extremity Implants Market Size, Share, Trends, Industry Analysis Report: By Type, Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Natural Biomaterials, and Polymeric Biomaterials), End Use and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The lower extremity implants market is experiencing strong growth, driven by the rising incidence of orthopedic disorders, advancements in implant materials and designs, and an aging global population. Lower extremity implants, used primarily for hip, knee, ankle, and foot surgeries, address a range of issues from fractures and deformities to severe joint degeneration. More people worldwide suffer from arthritis, osteoporosis, and other degenerative bone diseases, thus, the demand for effective and durable lower extremity implants continues to rise.
Technological advancements play a critical role in lower extremity implants market expansion. Innovations such as 3D printing, robotic-assisted surgery, and improved biocompatible materials have led to implants that offer better outcomes, longer durability, and less post-surgical recovery time. Additionally, the development of minimally invasive procedures has made these implants more accessible and appealing to patients by reducing surgical risks and recovery times.
Lower Extremity Implants Market Report Highlights
Based on type, the knee segment is accounted for the largest market share in 2024, due to the high prevalence of knee osteoarthritis and the increasing number of knee replacement surgeries. However, the hip segment is witnessing significant growth driven by advancements in surgical techniques and an increasing aging population prone to hip fractures.
In terms of end-use, the hospitals segment holds the largest market share, benefiting from comprehensive surgical facilities and the ability to handle complex cases. Ambulatory Surgery Centers (ASCs) are the fastest-growing segment, driven by the rising preference for outpatient procedures due to cost-effectiveness and quicker recovery times.
North America dominates the lower extremity implants market, driven by high healthcare expenditure, advanced medical infrastructure, and a large patient pool.
Asia Pacific is the fastest-growing region, spurred by a rapidly aging population, increasing healthcare investments, and rising awareness of advanced treatment options.
A few key players in the lower extremity implants market include companies such as Zimmer Biomet Holdings, Inc.; Stryker Corporation; DePuy Synthes (a Johnson & Johnson company); Smith & Nephew plc; and Wright Medical Group N.V. Other notable players are Exactech, Inc.; Medacta International SA; Orthofix Medical Inc.; Conformis, Inc.; and Globus Medical, Inc.
Polaris Market Research has segmented the lower extremity implants market report on the basis of type, biomaterial, end-use, and region:
By Type Outlook (Revenue, USD Million; 2020-2034)
Knee
Hip
Foot & Ankle
By Biomaterial Outlook (Revenue, USD Million; 2020-2034)
Metallic Biomaterials
Ceramic Biomaterials
Natural Biomaterials
Polymeric Biomaterials
By End-Use Outlook (Revenue, USD Million; 2020-2034)
Hospitals
Ambulatory Surgery Centers
Clinics
By Regional Outlook (Revenue, USD Million; 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Lower Extremity Implants Market Insights